Our data indicate that HF significantly reduces serum IL-1β levels and the inflammatory pathology in a murine model of DSS-induced colitis and highlight the therapeutic potential of HF-induced GCN2–AAR pathways in controlling intestinal inflammation. The gene discussed is IL1B; the disease is hydrops fetalis.